Daniel Gilmer
Board Member
Armata Pharmaceuticals, Inc. (ARMP)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel Gilmer
Daniel Gilmer is recorded as Board Member at Armata Pharmaceuticals, Inc. (ARMP). Armata Pharmaceuticals, Inc. reported in an 8-K filed April 27, 2026 that Daniel Gilmer was appointed member of the Board, effective April 24, 2026.
“On April 27, 2026, Armata Pharmaceuticals, Inc. (the “Company”) announced that the Board of Directors (the “Board”) appointed Dr. Daniel Gilmer, 39, as a member of the Board, effective as of April 24, 2026, to serve until the Company’s next annual meeting of the Company’s shareholders.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-04-24–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Armata Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Deborah Birx CEO
- Deborah L. Birx CEO, Board Member
- Dr. Deborah Birx CEO, Board Member
- Paul C. Grint CEO
- Richard J. Bastiani Chairman
- David House CFO
- Julianne Averill CFO
- Richard Rychlik CFO
- Erin Butler Chief Accounting Officer
- Dr. Daniel Gilmer Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.